SIREN : 830693800
STEROPES S.A.S is a French company founded 8 years ago, specialized in the sector Autres activités de soutien aux entreprises n.c.a.. Based in IGNY (91430), this company of category PME shows in 2024 a revenue of 597 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 597 034 € | 541 588 € | 468 727 € | 585 972 € | 829 300 € | 906 548 € | N/C | N/C |
| Net income | 473 877 € | -3 073 788 € | -3 230 057 € | -2 497 751 € | -2 110 177 € | -1 367 617 € | -47 541 € | -9 955 € |
| EBITDA | -238 726 € | -167 149 € | -178 205 € | -100 753 € | -136 545 € | -132 572 € | -443 742 € | -7 455 € |
| Net margin | 79.4% | -567.6% | -689.1% | -426.3% | -254.5% | -150.9% | N/C | N/C |
In 2024, STEROPES S.A.S achieves revenue of 597 k€. Revenue is declining over the period 2019-2024 (CAGR: -8.0%). Vs 2023, growth of +10% (542 k€ -> 597 k€). After deducting consumption (0 €), gross margin stands at 597 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -239 k€, representing -40.0% of revenue. Warning negative scissor effect: despite revenue change (+10%), EBITDA varies by -43%, reducing margin by 9.1 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 474 k€, i.e. 79.4% of revenue. This profit can be retained or distributed to shareholders.
597 034 €
597 034 €
-238 726 €
-327 890 €
473 877 €
-40.0%
The debt ratio (= Financial debt / Equity x 100) stands at 453%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 18%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 117.7 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 90.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
453.089%
17.957%
90.742%
117.691
In 2024, the debt ratio of STEROPES S.A.S (453.09) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of STEROPES S.A.S (18.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of STEROPES S.A.S (117.69) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 822.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
822.726
-1927.09
In 2024, the liquidity ratio of STEROPES S.A.S (822.73) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of STEROPES S.A.S (-1927.1x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 790 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 255 days. The gap of 535 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 1573 days of revenue, i.e. 2.6 M€ to permanently finance.
2 608 077 €
790 j
255 j
0 j
1573 j
Based on 131 transactions of similar company sales (all years), the value of STEROPES S.A.S is estimated at 756 146 € (range 251 794€ - 2 091 641€). The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare STEROPES S.A.S with other companies in the same sector:
Voir toutes les statistiques du secteur Autres activités de soutien aux entreprises n.c.a.
The revenue of STEROPES S.A.S in 2024 is 597 k€.
Yes, STEROPES S.A.S generated a net profit of 474 k€ in 2024.
The headquarters of STEROPES S.A.S is located in IGNY (91430), in the department Essonne.
The tax return of STEROPES S.A.S is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
STEROPES S.A.S operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.